Behavioral health dealmaking has risen steadily in 2025, falling short of the blockbuster year analysts had predicted. That tempered growth reflects two primary factors: uncertainty in the Medicaid market, one of the top payers in the behavioral health space, and the continued pressures of high interest rates and wage inflation. Over the summer, Congress approved […]
Rosecrance Behavioral Health
This is an exclusive BHB+ story Investors remain keen on pursuing behavioral health deals, sustaining healthy deal flow with occasional spikes in volume. The level of activity, which has overall cooled from record-setting historic levels, is largely seen as having recovered and settled into a new normal. What’s more, several organizations that delayed potential exits […]
This is a BHB+ exclusive article Operating an eating disorder treatment provider is no small feat, as doing so requires mental and physical health expertise. Over the last few years, we’ve seen a number of providers either exit or pull back on eating disorder treatment service lines. Most recently, Acadia Healthcare (Nasdaq: ACHC) announced a […]
This is an exclusive BHB+ story While the mental health sector has attracted steady investor interest and autism services have experienced a renewed awakening, the substance use disorder (SUD) treatment industry remains somewhat sleepy. In the first half of 2025, there were 18 deals in the SUD space, according to a recent report by M&A […]
Nonprofit therapy and substance use disorder (SUD) treatment provider Rosecrance Behavioral Health has acquired Ascend CHC. With this move, the Chicago-based company will add eating disorder care and specialty sports and performance counseling to its service lines. Terms of the deal were not disclosed. The acquired entity will now operate under the name “Rosecrance Ascend.” […]


